The latest news:

• Camp Jinka - NJ        From our friends at the Zocchi Brain Tumor Center
  



• Musella Foundation issues request for proposals for brain tumor research grants.         Our National Walk To End Brain Tumors was a big success! Thanks to all of our volunteers!   We will be sending out a mailing introducing our new Immunotherapy research fund soon! Watch for it or go to https://virtualtrials.com/immunotherapy_fund.cfm for details!
  



• Extended Survival Reported in Brain Cancer Patients Treated With Viral Gene Therapy         This treatment is now in a phase 2/3 trial for recurrent gbm, available in over 35 centers across the USA and Canada!  Go to https://clinicaltrials.gov/ct2/show/study/NCT02414165 for details!
  



• Cortice Biosciences Announces Presentation of Results from a Phase 1/2 Clinical Trial Evaluating TPI 287 for Treatment of Recurrent Glioblastoma at the Annual Meeting of the American Society of Clinical Oncology         Impressive results.
  



• Temozolomide Trial Shows Improved 5-Year Survival Rates in Anaplastic Glioma         We already knew this - but strangely I hear of many patients who do not get Temozolomide at the same time as radiation for Anaplastic Astrocytomas. This article should hopefully change that.  
  



• ImmunoCellular Therapeutics Treats First Patient in ICT-107 Phase 3 Registrational Trial in Newly Diagnosed Glioblastoma         Great news!  This is one of my favorite trials, and they are now open! This is a stock vaccine - which means you do not need fresh tumor tissue to make the vaccine.  It is a relatively simple blood draw and shot in the arm.
  



• Study: New Vaccine Helps Prevent Brain Tumors From Coming Back         This is another of my favorite treatments.  The video explains how the Toca 5 trial works! We are planning on launching a fundraising campaign to help speed up development of this exciting treatment!
  

BrainTumor Co-Payment Assistance Program Status:

• OPEN to new applicants